Tag Archives: Hepatitis C

01.23.19

Living in Fear of News Headlines: The Struggle to Maintain Mental and Emotional Health in Today’s Hostile Social Climate

By | Leave a Comment

I am scheduled to write a post to this blog about once a month. I usually scan through the most recent headlines in public health and health care to write about a timely issue. However, of late I have been overwhelmed by the amount of bleak information in today’s news – spanning from the mildly […]

Posted in Hepatitis C, Hepatitis C Staff Insights ; Tagged: , .

09.20.18

Congress Passes Major Opioid Response Legislation that Includes Funding to Improve Infectious Disease Surveillance

By | Leave a Comment

Monday, the Senate passed the Opioid Crisis Response Act by a 99-1 vote. The Act provides many changes to several federal health and human service programs to address opioid and substance use disorders. A critical component of this legislation is the inclusion of a $40 million appropriation from 2019-2023 to the Centers for Disease Control and […]

Posted in Hepatitis C, HIV, Infectious Diseases ; Tagged: .

08.09.18

New Study Develops The Most Comprehensive Dataset of U.S. Hepatitis C Patients and Epidemiology

By | Leave a Comment

A recent study published in July 2018 in the journal Advances in Therapy discusses the findings made by researchers who compiled the most comprehensive dataset available to describe the current hepatitis C landscape in the U.S. The study covers from 2013-2016, and, among other concerning statistics, shows a 234% increase in confirmed hepatitis C positive patients […]

Posted in Health reform, Healthcare, Hepatitis C, Infectious Diseases ; Tagged: , .

07.26.18

July 28 is World Hepatitis Day – Take the Time to LEARN MORE and DO MORE to Eliminate Viral Hepatitis Across the Globe

By | Leave a Comment

This Saturday, July 28th is World Hepatitis Day. It is a time to reflect on the global impact of viral hepatitis, and to raise awareness of the continued need for legislators and health care leaders to support measures that improve access to prevention, screening, and treatment of hepatitis infections.  The World Health Organization (WHO) estimates […]

Posted in Hepatitis C ; Tagged: , , .

05.31.18

Hepatitis Policy Project Releases New Report Telling the Stories of People Affected by Hepatitis C

By | Leave a Comment

The Institute’s Hepatitis Policy Project has released a new report that features the stories of people affected by hepatitis C. The report was authored by Sonia Canzater and Jeffrey S. Crowley. “Full of Life: The Stories of People Affected by Hepatitis C,” underscores the impact of hepatitis C and the potential for improving the lives of those with […]

Posted in Hepatitis C, Hepatitis C Staff Insights ; Tagged: , , .

04.03.18

Elimination Without Prevention — Mission Impossible

By | Leave a Comment

This article was written by Thelma Thiel, Founder and Chair of the Liver Health Initiative. Viewpoints included in this article do not necessarily reflect those of the O’Neill Institute, the Hepatitis Policy Project or its sponsors.  All the media attention highlighting the dramatic increase in opioid and other drug addition, as well as the rising […]

Posted in Hepatitis C, uncategorized ; Tagged: .

02.12.18

Actions Speak Louder than Words: Reclaiming Lost Ground in the Battles Against Viral Hepatitis

By | Leave a Comment

Expert Columnist post for the Hepatitis Policy Project at the O’Neill Institute for National and Global Health Law Written by Richard J. Wolitski, PhD, Director, and Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor Office of HIV/AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services Viral hepatitis […]

Posted in Hepatitis C ; Tagged: .

12.08.17

Planning for Success: Adequate Funding for Hepatitis C Surveillance and Monitoring is Vital to Achieving Elimination

By | Leave a Comment

This blog post was written by Sonia Canzater and Jeffrey S. Crowley of the O’Neill Institute, and originally published on December 6, 2017 on the HepVu blog. The original post can be found here.    These are the facts: An estimated 3.9 million Americans are infected with Hepatitis C Between 2010 and 2015, Hepatitis C incidence […]

Posted in Healthcare, Hepatitis C, Hepatitis C Staff Insights, uncategorized ; Tagged: , .

07.26.17

House Appropriations Committee passes FY2018 health services budget bill that offers no additional funding for HIV or viral hepatitis initiatives; does not acknowledge the rising rates of Hepatitis C infections in the U.S.

By | Leave a Comment

In a vote that followed party lines, the House Appropriations Committee passed the FY2018 Health and Human Services, Education, and Related Agencies Appropriations bill on July 20, 2017. The bill rejects most of the proposed cuts to health services recommended by the current Administration, but does little to boost funding for health services that desperately […]

Posted in Health reform, Healthcare, uncategorized ; Tagged: , , .

05.05.17

Louisiana Proposes that the Federal Government Bypass Patent Restrictions to Acquire Cheaper Hepatitis C Drugs

By | Leave a Comment

Anyone who follows U.S. public health issues – or who reads my blog posts – knows that the cost of the drugs needed to treat Hepatitis C infections is very high. The cost of these drugs is of particular concern to state health authorities who are charged with providing health care for Medicaid recipients and […]

Posted in FDA, Healthcare, uncategorized ; Tagged: .

  1. Pages:
  2. 1
  3. 2

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.